« FDA Warns Consumers in New Mexico and Texas Not to | Main | FDA Approvals - Key Challenges and Issues facing the World Cardiac Pacemakers Market »

FDA Approves Diaphragm-Pacing Device The U.S. Food and Drug Administration


FDA Approves Diaphragm-Pacing Device
The U.S. Food and Drug Administration today announced that it approved the NeuRx DPS RA/4 Respiratory Stimulation System, an implantable electronic device that stimulates the diaphragm and allows certain spinal cord injury patients to breathe for at least four hours a day without a mechanical ventilator.
 

©2006 FDA-News.com. All rights reserved.